Substance P is involved in the cutaneous blood flow increase response to sympathetic nerve stimulation in persistently inflamed rats

Journal of Physiological Sciences

Volumn 57, Issue 6, 2007, Pages 361-366

  Koeda, Tomoko ^a,b   Tamura, Ryoko ^a   Sato, Jun ^a   Mizumura, Kazue ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA GAKUIN UNIVERSITY   (Japan)

Author keywords

Adjuvant arthritic rats; Blood flow; Immunohistochemistry; Substance P; Sympathetic nerve stimulation

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; FREUND ADJUVANT; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROPEPTIDE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; ENANTIOMER; GANGLION; HORMONE RELEASE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NERVE ENDING; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SKIN BLOOD FLOW; SYMPATHETIC NERVE; VASODILATATION;

ADRENERGIC FIBERS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD PRESSURE; ELECTRIC STIMULATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; RATS; RATS, INBRED LEW; RECEPTORS, NEUROKININ-1; REGIONAL BLOOD FLOW; SKIN; SUBSTANCE P; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; VASODILATION;

EID: 38349125044     PISSN: 18806546     EISSN: None     Source Type: Journal    
DOI: 10.2170/physiolsci.RP007607     Document Type: Article

References (23)

1. Baron R. Complex regional pain syndromes. In: McMahon SB, Koltzenberg M, eds. Wall and Melzack's Textbook of Pain, 5th edition. Amsterdam: Elsevier; 2006. p. 1011-27.
2. Wasner G, Heckmann K, Maier C, and Baron R. Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I): complete inhibition of sympathetic nerve activity with recovery. Arch Neurol. 1999;56:613-20.
3. Kurvers HA, Tangelder GJ, De Mey JG, Slaaf DW, Beuk RJ, van den Wildenberg FA, Kitslaar PJ, Reneman RS, Jacobs MJ. Skin blood flow abnormalities in a rat model of neuropathic pain: result of decreased sympathetic vasoconstrictor outflow? J Auto Nerv Syst. 1997;63:19-29.
4. Wasner G, Schattschneider J, Heckmann K, Maier C, and Baron R. Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value. Brain 2001;124:587-99.
5. Lundberg J, Norgren L, Ribbe E, Rosen I, Steen S, Thorne J et al. Direct evidence of active sympathetic vasodilatation in the skin of the human foot. J Physiol. 1989; 417:437-46.
6. McDougall JJ, Karimian SM, Ferrell WR. Alteration of substance P-mediated vasodilatation and sympathetic vasoconstriction in the rat knee joint by adjuvant-induced inflammation. Neurosci Lett. 1994;174:127-9.
7. McDougall JJ, Karimian SM, Ferrell WR. Prolonged alteration of vasoconstrictor and vasodilator responses in rat knee joints by adjuvant monoarthritis. Exp Physiol. 1995;80:349-57.
8. Lam FY, Ferrell WR. Acute inflammation in the rat knee joint attenuates sympathetic vasoconstriction but enhances neuropeptide-mediated vasodilatation assessed by laser Doppler perfusion imaging. Neuroscience 1993;52:443-9.
9. Koeda T, Sato J, Kumazawa T, Tsujii Y, and Mizumura K. Effects of alpha-adrenoceptor antagonists on the cutaneous blood flow increase response to sympathetic nerve stimulation in rats with persistent inflammation. Jpn J Physiol. 2002;52:521-30.
10. Lam FY and Ferrell WR. Effects of interactions of naturally-occurring neuropeptides on blood flow in the rat knee joint. Br J Pharmacol. 1993;108:694-9.
11. Guo TZ, Offley SC, Boyd EA, Jacobs CR, Kingery WS. Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I. Pain 2004;108:95-107.
12. Donnerer J.; Schuligoi R.; Stein C.; Amann R.: Upregulation, release and axonal transport of substance P and calcitonin gene-related peptide in adjuvant inflammation and regulatory function of nerve growth factor. Regul Pept. 1993;46:150-4.
13. Lewin GR and Mendell LM. Nerve growth factor and nociception. Trends Neurosci. 1993;16:353-9.
14. Zigmond RE and Sun Y. Regulation of neuropeptide expression in sympathetic neurons. Ann NY Acad Sci. 1997;814:181-97.
15. Gamse R, Wax A, Zigmond RE, Leeman SE. Immunoreactive substance P in sympathetic ganglia: distribution and sensitivity towards capsaicin. Neuroscience 1981;6:437-41.
16. Anderson DJ. Molecular control of cell fate in the neural crest: the sympathoadrenal lineage. Annu Rev Neurosci. 1993;16:129-58.
17. Wooten GF, Kopin IJ, Axelrod J. Effects of colchicine and vinblastine on axonal transport and transmitter release in sympathetic nerves. Ann NY Acad Sci. 1975;253:528-34.
18. Grimsholm O, Rantapaa-Dahlqvist S, Forsgren S. Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. Arthritis Res Ther. 2005;7:R416-26.
19. Shadiack AM, Hart RP, Carlson CD, and Jonakait GM. Interleukin-1 induces substance P in sympathetic ganglia through the induction of leukemia inhibitory factor (LIF). J Neurosci. 1993;13:2601-9.
20. Jonakait GM and Hart RP. Immune cytokine regulation of sympathetic ganglion response to injury. Neuroimmunomodulation 1995;2:236-40.
21. Donnerer J, Schuligoi R, and Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neurosci. 1992;49 (3):693-8.
22. Janig W. The sympathetic nervous system in pain. In Stanton-Hicks M, editors. Pain and the sympathetic nervous system. Boston: Kluwer Academic Pub; 1990: p. 17-89.
23. Sato J, Suzuki S, Iseki T, Kumazawa T. Adrenergic excitation of cutaneous nociceptors in chronically inflamed rats. Neurosci Lett. 1993;164:225-8.